✦ LIBER ✦

9248 Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Natale, R.; Charu, V.; Schütte, W.; Albert, I.; Tehenes, S.; McCoy, J.; Berger, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of Romiplostim in the Treatment

✍ Judit Demeter; Ildiko Istenes; Anikó Fodor; Melinda Paksi; Peter Dombi; Erika Va 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 109 KB

Gefitinib in the treatment of elderly pa

✍ Bearz, Alessandra; Fratino, Lucia; Spazzapan, Simon; Berretta, Massimiliano; Gia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Safety and feasibility of radiotherapy t

✍ F. Fiorica; F. Cartei; S. Ursino; A. Stefanelli; Y. Zagatti; S. Berretta; S. Fig 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 403 KB

Erlotinib treatment results in patients

✍ Salajka, F.; Pešek, M.; Skřičková, J.; Zatloukal, P.; Koubková, L.; Grygárková, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Systemic chemotherapy as a primary treat

✍ Lee, J.S; Pisters, K.M; Komaki, R; Terry, K; Glisson, B.S; Perez-Soler, R; Fosse 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Safety and efficacy of cetuximab combine

✍ Xiaoyan Si; Li Zhang 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 75 KB